ZA796918B - Pharmaceutical composition for treating neoplastic diseases and methods of preparation - Google Patents
Pharmaceutical composition for treating neoplastic diseases and methods of preparationInfo
- Publication number
- ZA796918B ZA796918B ZA00796918A ZA796918A ZA796918B ZA 796918 B ZA796918 B ZA 796918B ZA 00796918 A ZA00796918 A ZA 00796918A ZA 796918 A ZA796918 A ZA 796918A ZA 796918 B ZA796918 B ZA 796918B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- methods
- pharmaceutical composition
- neoplastic diseases
- treating neoplastic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA796918B true ZA796918B (en) | 1980-11-26 |
Family
ID=25518727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA00796918A ZA796918B (en) | 1978-12-21 | 1979-12-20 | Pharmaceutical composition for treating neoplastic diseases and methods of preparation |
Country Status (16)
Country | Link |
---|---|
US (1) | US4384001A (zh) |
JP (1) | JPS55115822A (zh) |
AU (1) | AU5390579A (zh) |
BE (1) | BE880744A (zh) |
CA (1) | CA1149284A (zh) |
DE (1) | DE2951050A1 (zh) |
DK (1) | DK542979A (zh) |
ES (1) | ES8102108A1 (zh) |
FR (1) | FR2444459A1 (zh) |
GB (1) | GB2039736B (zh) |
IL (1) | IL58948A0 (zh) |
IT (1) | IT1193348B (zh) |
LU (1) | LU82013A1 (zh) |
NL (1) | NL7909199A (zh) |
SE (1) | SE7910300L (zh) |
ZA (1) | ZA796918B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
DE3586683T2 (de) * | 1984-12-18 | 1993-04-08 | Clark Pharma Dev | Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln. |
JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
JPH01170063U (zh) * | 1988-05-11 | 1989-11-30 | ||
JPH0467539U (zh) * | 1990-10-18 | 1992-06-16 | ||
EP0494405B2 (en) * | 1991-01-10 | 2000-04-19 | Transcend Therapeutics, Inc. | Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases |
ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/xx unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-19 CA CA000342263A patent/CA1149284A/en not_active Expired
- 1979-12-19 ES ES487052A patent/ES8102108A1/es not_active Expired
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
SE7910300L (sv) | 1980-06-22 |
BE880744A (fr) | 1980-06-19 |
AU5390579A (en) | 1980-06-26 |
LU82013A1 (fr) | 1981-02-03 |
JPS6328045B2 (zh) | 1988-06-07 |
ES487052A0 (es) | 1980-12-16 |
NL7909199A (nl) | 1980-06-24 |
GB2039736B (en) | 1983-04-13 |
DE2951050A1 (de) | 1980-07-10 |
IT1193348B (it) | 1988-06-15 |
CA1149284A (en) | 1983-07-05 |
ES8102108A1 (es) | 1980-12-16 |
GB2039736A (en) | 1980-08-20 |
IL58948A0 (en) | 1980-03-31 |
FR2444459B1 (zh) | 1983-04-01 |
US4384001A (en) | 1983-05-17 |
FR2444459A1 (fr) | 1980-07-18 |
IT7928170A0 (it) | 1979-12-18 |
JPS55115822A (en) | 1980-09-06 |
DK542979A (da) | 1980-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2013495A (en) | Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias | |
JPS54119025A (en) | Tickening of cosmetic * pharmaceutical and technical preparation | |
GB2029218B (en) | Pharmaceutical composition for treatment of cardiovascular disease | |
GB2028826B (en) | Acyl-derivatives of carnitine and process for their preparation | |
JPS54113442A (en) | Treating agent of hyperlipoid disease | |
GB2086390B (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application | |
IL56612A0 (en) | 1-aryloxy-4-nitratoalkylamino-2-propanols and process for their preparation | |
ZA79264B (en) | 2h-benzofuran-3-one-derivatives and process for their preparation | |
ZA796918B (en) | Pharmaceutical composition for treating neoplastic diseases and methods of preparation | |
HU179689B (en) | Pharmaceutical composition against psoriasis and process for preparing such composition | |
MY8700122A (en) | N-oxacyclic-alkylpeperidyl-diazacompounds process for their manufacture and pharmaceutical compositions containing them | |
PT73061B (en) | Process for the preparation of new derivatives of taurina and its pharmaceutical use | |
IL56895A0 (en) | Phenoxyalkylamines and process for their preparation | |
GB2030294B (en) | Composition for determination of human b-microglobulin process for its preparation and its use | |
GB2030293B (en) | Composition for determination of human immunoglobulin g process for its preparation and its use | |
GB2022998B (en) | Phermaceutical composition for the treatment of neoplasticand other diseases | |
GB2038802B (en) | Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them | |
PT70556A (en) | Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines | |
JPS539757A (en) | Production of taunorbicine derivatives and pharmaceutical composition for treating tumor of human | |
GB2076399B (en) | Process for the manufacture of novel benzazole derivatives pharmaceutical preparations containing these derivatives and their use | |
CY1290A (en) | Azathianaphthalene derivatives process for their manufacture pharmaceutical preparations containing them and their use | |
DE3065252D1 (en) | Medicinal preparation for the treatment of carcinoma and process for preparing it | |
AU4717679A (en) | Herbal cream for treatment of diseases | |
ZA795895B (en) | Ravidomycin and process of preparation | |
ZA79449B (en) | Therapeutic method for the treatment of hyperlipoproteinaemias and hyperlipodaemias |